Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 1 2Phase 3 1Phase 2 1Phase 1/2 1

Status

Completed 5Unknown 1Active not recruiting 1

Sponsor Class

INDUSTRY 7OTHER 4

Study Type

Interventional 7Observational 1

Sponsor

Cancer Type

Dermatologic 3Other neoplasm 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Keratosis, Actinic 3Neoplasms 2Keratosis 2Stomach Neoplasms 1Precancerous Conditions 1Lymphoma 1Leukemia, Myeloid, Acute 1Carcinoma 1Breast Neoplasms 1Bone-Metastatic, Castration-Resistant Prostate Cancer 1

Interventions

pembrolizumab 1023Carboplatin 964Paclitaxel 933Gemcitabine 794Cisplatin 751Docetaxel 683Bevacizumab 609Pemetrexed 502Nivolumab 487Cyclophosphamide 471Capecitabine 461Fluorouracil 418Dexamethasone 403Rituximab 372Oxaliplatin 348Injections 345atezolizumab 298Trastuzumab 298Leucovorin 288Cetuximab 282Irinotecan 268130-nm albumin-bound paclitaxel 254Prednisone 245Doxorubicin 240Ipilimumab 226Lenalidomide 220fludarabine 218Fulvestrant 217durvalumab 205Erlotinib Hydrochloride 188

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × tirbanibulin × Clear all
NCT06135415 2026-03-25

TirbAKare

Almirall, S.A.

Phase 3 Completed
280 enrolled
DermatologicOther neoplasm

Keratosis, Neoplasms, Precancerous Conditions, Keratosis, Actinic

NCT05741294 2025-02-20

A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses

Almirall, S.A.

Phase 4 Completed
334 enrolled 12 charts
Dermatologic

Keratosis, Keratosis, Actinic

NCT05387525 2025-02-11

AKtive

Almirall, S.A.

Phase 4 Active not recruiting
447 enrolled
Dermatologic

Keratosis, Actinic

NCT01074138 2023-02-02

Safety and Efficacy Study of KX2-391 for Treatment of Bone-Metastatic, Castration-Resistant Prostate Cancer

Athenex, Inc.

Phase 2 Completed
31 enrolled
Genitourinary

Bone-Metastatic, Castration-Resistant Prostate Cancer

NCT01397799 2015-12-07

Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)

Athenex, Inc.

Phase 1 Completed
24 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01764087 2015-05-18

A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors

Hanmi Pharmaceutical Company Limited

Phase 1/2 Unknown
60 enrolled
BreastGastrointestinal

Breast Neoplasms, Carcinoma, Neoplasms, Stomach Neoplasms

NCT00658970 2011-06-08

Evaluation of KX2-391 in Patients With Advanced Malignancies

Athenex, Inc.

Phase 1 Completed
50 enrolled
Lymphoid

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡